Covered recipient · General Payments record
SHANE TATAR
Physician Assistants & Advanced Practice Nursing Providers Physician Assistant Medical
General Payments · PY2021–2024
$2,444.08
- Reported across 91 records
- CMS publication 2026-01-23
Financial relationships do not necessarily indicate an improper relationship; the data is open to interpretation.
How these totals are calculated
- The total is the sum of the General Payments records CMS published for the labeled program year(s), exactly as published. Nothing is estimated, weighted, or combined across categories.
- General Payments only. Research and Ownership/Investment are separate datasets and are never summed with these figures; amounts are kept separate per program year.
- Featured-page threshold (a presentation gate, not a judgment): records>=3 OR total>=100 (all years).
- Methodology & Data — sourcing, labeling, and limitations.
By nature of payment
PY2024 · sorted by reported total
| Nature of payment | Amount | Records |
|---|---|---|
| Food and Beverage | $623.03 | 19 |
By paying entity
PY2024 · sorted by reported total
| Paying entity | Amount | Records |
|---|---|---|
| Novo Nordisk AS | $250.03 | 10 |
| ABBVIE INC. | $223.63 | 3 |
| Acerta Pharma LLC | $58.23 | 3 |
| INTRA-SANA LABORATORIES | $50.00 | 1 |
| GlaxoSmithKline, LLC. | $41.14 | 2 |
By program year
All program years on this page · sorted by year
Payment records · PY2024 (19)
Sorted by paying entity, then date · as published by CMS
| Paying entity | Amount | Date | Nature of payment | Dispute status | Published | Record ID | Source |
|---|---|---|---|---|---|---|---|
| ABBVIE INC. | $105.47 | 09/18/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1108287529 | CMS |
| ABBVIE INC. | $101.91 | 10/17/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1108287531 | CMS |
| ABBVIE INC. | $16.25 | 10/17/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1108287533 | CMS |
| AstraZeneca Pharmaceuticals LP | $14.86 | 01/25/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1105705296 | CMS |
| AstraZeneca Pharmaceuticals LP | $22.71 | 05/28/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1104402675 | CMS |
| AstraZeneca Pharmaceuticals LP | $20.66 | 12/10/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1105608903 | CMS |
| GlaxoSmithKline, LLC. | $13.85 | 06/14/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1116377804 | CMS |
| GlaxoSmithKline, LLC. | $27.29 | 11/21/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1116579472 | CMS |
| Intra-Sana Laboratories | $50.00 | 01/25/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1138622650 | CMS |
| Novo Nordisk Inc | $21.72 | 01/18/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1100326356 | CMS |
| Novo Nordisk Inc | $3.18 | 02/01/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1100278116 | CMS |
| Novo Nordisk Inc | $7.29 | 02/01/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1100381437 | CMS |
| Novo Nordisk Inc | $125.00 | 04/03/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1100374541 | CMS |
| Novo Nordisk Inc | $17.53 | 04/08/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1100444897 | CMS |
| Novo Nordisk Inc | $15.93 | 07/11/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1100451114 | CMS |
| Novo Nordisk Inc | $18.62 | 07/25/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1100513765 | CMS |
| Novo Nordisk Inc | $23.98 | 09/30/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1100500899 | CMS |
| Novo Nordisk Inc | $13.11 | 10/31/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1100624330 | CMS |
| Novo Nordisk Inc | $3.67 | 11/26/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1100455738 | CMS |
Source & provenance
- Dataset
- CMS Open Payments — General Payments
- Publisher of source data
- Centers for Medicare & Medicaid Services
- CMS publication date
- 2026-01-23
- Program years on this page
- 2021, 2022, 2023, 2024
- Generated from
- OP_DTL_GNRL_PGYR2024_P01232026_01102026.csv
One page per canonical provider; split Profile_IDs are merged via Associated_Covered_Recipient_Profile_ID_1/_2 from the Covered Recipient Profile Supplement.
Corrections to the substance of a record route to CMS through its review-and-dispute process; errors in how this site mirrors or displays a record route to us. Both paths are described in Methodology & Data.